Cargando…
Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes
BACKGROUND: The number of people with diabetes is increasing and resulting in major economic losses. Presenteeism accounts for the majority of economic losses, so measures against presenteeism are important. This study investigated the relationship between severity of type 2 diabetes and presenteeis...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520264/ https://www.ncbi.nlm.nih.gov/pubmed/34654398 http://dx.doi.org/10.1186/s12889-021-11913-3 |
_version_ | 1784584633810157568 |
---|---|
author | Mori, Takahiro Nagata, Tomohisa Nagata, Masako Fujimoto, Kenji Fujino, Yoshihisa Mori, Koji |
author_facet | Mori, Takahiro Nagata, Tomohisa Nagata, Masako Fujimoto, Kenji Fujino, Yoshihisa Mori, Koji |
author_sort | Mori, Takahiro |
collection | PubMed |
description | BACKGROUND: The number of people with diabetes is increasing and resulting in major economic losses. Presenteeism accounts for the majority of economic losses, so measures against presenteeism are important. This study investigated the relationship between severity of type 2 diabetes and presenteeism. METHODS: A cross-sectional study was conducted among workers over 40 years of age. Participants were classified as normal group or diabetic treatment group using their medical examination results and health insurance claims data. Diabetic treatment groups were described by degree of treatment control: Good (HbA1c < 7%), Intermediate (7% ≤ HbA1c < 8%), and Poor (8% ≤ HbA1c). Therapy type was also divided into monotherapy and combination therapy. Logistic regression analysis was performed to predict presenteeism loss using the Quantity and Quality method. RESULTS: Data on 13,271 workers were analyzed. Presenteeism loss was significantly higher in all treatment control groups compared with the normal group, particularly for the intermediate and poor control groups. The monotherapy group did not differ from the normal group, but presenteeism loss was significantly higher in the combination therapy group than the normal group. CONCLUSIONS: Presenteeism loss in workers with diabetes may be affected by diabetes severity, and even if treatment control were good, presenteeism loss could occur when the number of anti-diabetic drugs was high. Therefore, it is important to provide early intervention and continuous support as a preventive measure against not only diabetes and diabetes-related complications but also presenteeism. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-11913-3. |
format | Online Article Text |
id | pubmed-8520264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85202642021-10-20 Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes Mori, Takahiro Nagata, Tomohisa Nagata, Masako Fujimoto, Kenji Fujino, Yoshihisa Mori, Koji BMC Public Health Research BACKGROUND: The number of people with diabetes is increasing and resulting in major economic losses. Presenteeism accounts for the majority of economic losses, so measures against presenteeism are important. This study investigated the relationship between severity of type 2 diabetes and presenteeism. METHODS: A cross-sectional study was conducted among workers over 40 years of age. Participants were classified as normal group or diabetic treatment group using their medical examination results and health insurance claims data. Diabetic treatment groups were described by degree of treatment control: Good (HbA1c < 7%), Intermediate (7% ≤ HbA1c < 8%), and Poor (8% ≤ HbA1c). Therapy type was also divided into monotherapy and combination therapy. Logistic regression analysis was performed to predict presenteeism loss using the Quantity and Quality method. RESULTS: Data on 13,271 workers were analyzed. Presenteeism loss was significantly higher in all treatment control groups compared with the normal group, particularly for the intermediate and poor control groups. The monotherapy group did not differ from the normal group, but presenteeism loss was significantly higher in the combination therapy group than the normal group. CONCLUSIONS: Presenteeism loss in workers with diabetes may be affected by diabetes severity, and even if treatment control were good, presenteeism loss could occur when the number of anti-diabetic drugs was high. Therefore, it is important to provide early intervention and continuous support as a preventive measure against not only diabetes and diabetes-related complications but also presenteeism. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-11913-3. BioMed Central 2021-10-16 /pmc/articles/PMC8520264/ /pubmed/34654398 http://dx.doi.org/10.1186/s12889-021-11913-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mori, Takahiro Nagata, Tomohisa Nagata, Masako Fujimoto, Kenji Fujino, Yoshihisa Mori, Koji Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes |
title | Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes |
title_full | Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes |
title_fullStr | Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes |
title_full_unstemmed | Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes |
title_short | Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes |
title_sort | diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520264/ https://www.ncbi.nlm.nih.gov/pubmed/34654398 http://dx.doi.org/10.1186/s12889-021-11913-3 |
work_keys_str_mv | AT moritakahiro diabetesseveritymeasuredbytreatmentcontrolstatusandnumberofantidiabeticdrugsaffectspresenteeismamongworkerswithtype2diabetes AT nagatatomohisa diabetesseveritymeasuredbytreatmentcontrolstatusandnumberofantidiabeticdrugsaffectspresenteeismamongworkerswithtype2diabetes AT nagatamasako diabetesseveritymeasuredbytreatmentcontrolstatusandnumberofantidiabeticdrugsaffectspresenteeismamongworkerswithtype2diabetes AT fujimotokenji diabetesseveritymeasuredbytreatmentcontrolstatusandnumberofantidiabeticdrugsaffectspresenteeismamongworkerswithtype2diabetes AT fujinoyoshihisa diabetesseveritymeasuredbytreatmentcontrolstatusandnumberofantidiabeticdrugsaffectspresenteeismamongworkerswithtype2diabetes AT morikoji diabetesseveritymeasuredbytreatmentcontrolstatusandnumberofantidiabeticdrugsaffectspresenteeismamongworkerswithtype2diabetes |